General
publicado em 03/02/2011 às 02h00:00
   Dê o seu voto:

Synthetic compound prevents pain crises in sickle cell anemia

Aptamer against cell adhesion preventing RBCs from sickle accumulate in small blood vessels

 
font size
A-
A+

Some pieces of information on this page may have been automatically translated. Makernews is not responsible for the irregularities resulting from these translations. When in doubt,      consult the original text.



Foto: Phil Jones/GHSU
From left to right: Dr. Diana R. Gutsaeva, C. Alvin Head, Tohru Ikuta and James B. Parkerson
  « Previous
next »  
From left to right: Dr. Diana R. Gutsaeva, C. Alvin Head, Tohru Ikuta and James B. Parkerson

Synthetic compound prevents congestion of cells that causes episodes of debilitating pain and mortality associated with sickle cell anemia, according to researchers at the Medical College of Georgia, USA.

The aptamer developed by Archemix Corporation in the United States, works occupying the receptors sticky lining the walls of small blood vessels where red blood cells sickle-shaped and white cells can accumulate. Bottling cell blocks the flow of blood and oxygen, causing pain and organ damage, and possibly death.

Functional

In mice with the disease, the administration of the aptamer before a painful crisis reduced the adhesion of sickle erythrocytes in 90% and white blood cells by 80%. The animals also had increased blood flow velocity and reduction in mortality.

Researchers argue that the compound can now proceed to clinical trials with the potential to treat an acute painful crisis, dealt with drugs today. The current form of the aptamer is liquid and it was administered intravenously or injected under the skin.

The new aptamer targets the receptor P-selectin, which are highly expressed in patients with sickle cell anemia.

"The aptamer blocks the receptors so they do not work," said study co-author, Tohru Ikuta. "There is almost no good compound that inhibits cell adhesion and many are toxic. At least in animal studies, the new compound is not toxic and does not provoke an immune response."

"Many people are focusing on developing new therapies for sickle cell disease, because today there is only one choice approved by the FDA (hydroxyurea, a chemotherapeutic agent)," explained study author, Diana R. Gutsaeva. "We believe that this aptamer has the potential to be one of the new therapies."

Source: Isaude.net
   Palavras-chave:   SCD    Synthetic compound    Aptamer    Red blood cells    Medical College of Georgia   
  • Share this pageShare this page
  • Share this pageCorrect
  • ShareShare
  • AlertAlert
Reduced link: 
  • You are recommending this story: Synthetic compound prevents pain crises in sickle cell anemia
  • Fill in the following form to send your recommendation to your friend:

  • You are suggesting a correction for this story: Synthetic compound prevents pain crises in sickle cell anemia


Receba notícias do iSaúde no seu e-mail de acordo com os assuntos de seu interesse.
Seu nome:
Seu email:
Desejo receber um alerta com estes assuntos:
SCD    synthetic compound    aptamer    red blood cells    Medical College of Georgia   
Comments:
Comment
Leave your comment
Close
(Required fields are marked with an *)

(Your email address will never be published or shared.)

Enter the letters and numbers below and click in the button "send"

  • Twitter iSaúde
advertising
Informe Saúde printed version

Recommend the portal
Close [X]
  • You are recommending this story: http://www.isaude.net
  • Fill in the following form to send your recommendation to your friend:

RSS news from the portal  iSaúde.net
Get the newsletter of the portal  iSaúde.net
Recommend the portal iSaúde.net
News from  iSaúde.net in your blog or website.
Get news on the subject of your interest.
© 2000-2011 www.isaude.net Todos os direitos reservados.